Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
A PROJECT OF THE INDEPENDENT INSTITUTE
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Home
2019
March
Monthly Archives: March 2019
Blog
FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression
Raymond March
-
March 28, 2019
0
Blog
Generic Insulin Now Available After Nearly One Hundred Years of Regulatory Protection From Competition
Raymond March
-
March 25, 2019
0
Blog
FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?
Raymond March
-
March 14, 2019
0
Blog
FDA Panel Backs Ketamine-Based Treatment for Depression
Raymond March
-
March 1, 2019
0
